At the moment the medicine in Vydura, Rimegepant, is under patent. This means that only one medicine company in the UK, Pfizer, is allowed to manufacture it and they set the price.
We are not sure when Vydura will come “off patent” but it is likely to be around 2040.
After this, other companies will be able to manufacture Rimegepant tablets. This increased competition among manufacturers will cause the price to drop, these savings will then be passed on to the customer.